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Abstract
Background: Accelerated knee osteoarthritis (AKOA) is characterized by more pain, impaired physical function, and
greater likelihood to receive a joint replacement compared to individuals who develop the typical gradual onset of
disease. Prognostic tools are needed to determine which structural pathologies precede the development of AKOA
compared to individuals without AKOA. Therefore, the purpose of this manuscript was to determine which pre-
radiographic structural features precede the development of AKOA.
Methods: The sample comprised participants in the Osteoarthritis Initiative (OAI) who had at least one
radiographically normal knee at baseline (Kellgren-Lawrence [KL] grade < 1). Participants were classified into 2
groups based on radiographic progression from baseline to 48 months: AKOA (KL grade change from < 1 to > 3)
and No AKOA. The index visit was the study visit when participants met criteria for AKOA or a matched timepoint
for those who did not develop AKOA. Magnetic resonance (MR) images were assessed for 12 structural features at
the OAI baseline, and 1 and 2 years prior to the index visit. Separate logistic regression models (i.e. OAI baseline, 1
and 2 years prior) were used to determine which pre-radiographic structural features were more likely to antedate
the development of AKOA compared to individuals not developing AKOA.
Results: At the OAI baseline visit, degenerative cruciate ligaments (Odds Ratio [OR] = 2.2, 95% Confidence Interval
[CI] = 1.3,3.5), infrapatellar fat pad signal intensity alteration (OR = 2.0, 95%CI = 1.2,3.2), medial/lateral meniscal
pathology (OR = 2.1/2.4, 95%CI = 1.3,3.4/1.5,3.8), and greater quantitative knee effusion-synovitis (OR = 2.2, 95%CI = 1.
4,3.4) were more likely to antedate the development of AKOA when compared to those that did not develop
AKOA. These results were similar at one and two years prior to disease onset. Additionally, medial meniscus
extrusion at one year prior to disease onset (OR = 3.5, 95%CI = 2.1,6.0) increased the likelihood of developing AKOA.
Conclusions: Early ligamentous degeneration, effusion/synovitis, and meniscal pathology precede the onset of
AKOA and may be prognostic biomarkers.
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Background
While knee osteoarthritis (OA) is typically is a gradually
progressive disorder, a subset of individuals develop an
accelerated form of the disease that is defined by the
rapid onset and progression of disease within 4 years,
and oftentimes within 12months [1–3]. Accelerated
knee OA (AKOA) represents a greater personal burden
compared to typical knee OA, because individuals with
AKOA are more likely to report frequent knee pain and
greater self-reported global impact of arthritis (i.e., 0–10
global rating scale), as well as present with decreased
physical function performance (e.g. slower walking and
chair-stand pace) [2]. Additionally, AKOA represents an
increased economic burden, as individuals with AKOA
are more likely to receive pharmacological/surgical treat-
ments and knee replacements compared with individuals
with typical knee OA [4]. Therefore, developing prog-
nostic tools that can distinguish between people who
will develop AKOA are needed to lessen the personal
and economic burden of this disease.
There is preliminary evidence that alterations in the
meniscus and subchondral bone may characterize the
onset of AKOA [5]. However, since knee OA is a disease
that affects all structures of the joint [6], a more
in-depth investigation of alterations in pre-radiographic
structural features is needed. Magnetic resonance (MR)
imaging offers a comprehensive assessment that evalu-
ates cartilage, subchondral bone, meniscus, ligaments,
tendons, and synovium. The annual MR image assess-
ments of the Osteoarthritis Initiative (OAI) in individ-
uals with radiographically normal knees allows for the
unique ability to monitor early pre-radiographic struc-
tural alterations prior to the rapid decline in joint health
associated with AKOA.
The primary purpose of this analysis was to determine
which pre-radiographic structural features at key OAI
visits precede the radiographic development of AKOA.
Due to the rapid radiographic decline in joint health in
individuals with AKOA, we hypothesize that early de-
generative changes in the cruciate ligaments, extensor
mechanism, and proximal gastrocnemius tendons
would be associated with the future onset of AKOA.
Furthermore, we hypothesized the effusion/synovitis
and the presence of meniscal pathology would be as-
sociated with the onset of AKOA. Additionally, we
explored which combination of pre-radiographic
structural features may best discriminate which indi-
viduals will develop AKOA. The results of these ana-
lyses will indicate which pre-radiographic structural
features may be ideal prognostic imaging markers for
future AKOA development. These imaging markers
will be imperative for selecting individuals at risk for
AKOA to assess and deploy prevention strategies for
incident AKOA.
Methods
Study design and participant selection
We identified individuals for this study using radio-
graphic data from the OAI baseline and first 4 annual
follow-up visits. The OAI is a multicenter (Memorial
Hospital of Rhode Island, The Ohio State University,
University of Maryland and Johns Hopkins University,
and the University of Pittsburgh) cohort study that re-
cruited 4796 adults with or at risk for symptomatic knee
OA between February 2004 and May 2006 [7]. Institu-
tional review boards at all OAI clinical sites and the OAI
coordinating center (University of California, San Fran-
cisco) approved the OAI study. Participants provided in-
formed consent prior to participation.
For this study, readers assessed 12 knee features on MR
images at the OAI baseline visit, as well as at specific
timepoints relative to the onset of disease (i.e. 2 and 1
years prior to onset of disease). Key features include
semi-quantitative readings (i.e. collateral ligaments, cruci-
ate ligaments, extensor mechanism, gastrocnemius ten-
dons, infrapatellar fat pad signal intensity alteration,
menisci) and quantitative measures (i.e. effusion-synovitis,
bone marrow lesion [BML], and cartilage).
Participant selection
Participants in all groups were identified based on an-
nual radiographs from the baseline to the 48-month
OAI visit [3]. All groups had at least one knee with no
radiographic knee OA at baseline (Kellgren-Lawrence
[KL] < 1). Individuals who developed AKOA were de-
fined as having one knee progress to advanced-stage
knee OA (KL Grade = 0/1 to 3/4, definitive osteophyte
and joint space narrowing) within 48 months (n = 125)
[3]. Individuals with typical knee OA experienced a
more gradual onset of OA and were defined as having
one knee increase in KL grade within 48 months (i.e. KL
= 0 to 1, 0 to 2, 1 to 2; n = 187). Individuals were defined
as having no knee OA if both knees had no change in
KL grade from baseline to the 48-month OAI visit (n =
1325). Individuals in the typical and no knee OA group
were randomly matched to the AKOA group based on
sex. Each group had 125 participants. For data analysis,
we combined the typical knee OA and no knee OA
groups into a single “no AKOA” group to allow for a
comparison between individuals who would and would
not develop AKOA [8].
Index knee
The index knee in individuals with AKOA or typical
knee OA was defined as the first knee to meet the
definition of AKOA or typical knee OA, respectively.
The index knee in individuals with no knee OA was
the same knee as that person’s matched member of
the AKOA group.
Harkey et al. BMC Musculoskeletal Disorders          (2019) 20:241 Page 2 of 10
Index visit
For individuals with AKOA or typical knee OA, the
index visit was defined as the visit when a person first
met the definition for AKOA or typical knee OA. For
someone with no knee OA the index visit was the same
visit as that person’s matched member of the incident
AKOA group. The index visit could be at a 12-, 24-, 36-,
or 48-month OAI visit.
Knee radiographs
To determine group assignment, we used readings of bi-
lateral weight-bearing, fixed-flexion posteroanterior knee
radiographs obtained at baseline and each annual
follow-up visits [3]. Central readers blinded to group as-
signment scored the KL Grade of each knee (KL = 0 to
4). The intrarater reliability agreement for the KL grades
was good (weighted κ = 0.70 to 0.80) [9]. These data are
publicly available (files: kXR_SQ_BU##_SAS [versions
0.6, 1.6, 3.5, 5.5, and 6.3]) [10].
MR imaging
MR acquisition
All semi-quantitative and quantitative analyses were con-
ducted in index knees at the OAI baseline visit, as well as
at 2 and 1 years prior to the index visit. MR images were
acquired with one of four identical Siemens (Erlangen,
Germany) Trio 3-Tesla MR systems at each clinical site
using the OAI MR imaging protocol [10, 11]. The two
musculoskeletal radiologists (RW, JM) performing
semi-quantitative scoring were provided all the sequences
acquired on each index knee at each visit (e.g., sagittal
intermediate-weighted, turbo spin echo, fat-suppressed
MR sequence; coronal intermediate-weighted, turbo spine
echo, sequence without fat suppression, 3-dimensional
dual-echo steady-state sequence). The quantitative mea-
sures of BML and effusion-synovitis were performed using
a sagittal intermediate-weighted, turbo spin echo,
fat-suppressed MR sequence: field of view = 160mm, slice
thickness = 3mm, skip = 0mm, flip angle = 180 degrees,
echo time = 30ms, recovery time = 3200ms, 313 × 448
matrix, x resolution = 0.357mm, y resolution = 0.511mm,
and total slice number = 37. Cartilage damage index was
quantified using a 3-dimensional dual-echo steady-state
sequence: field of view = 140mm, slice thickness = 0.7
mm, skip = 0mm, flip angle = 25 degrees, echo time = 4.7
ms, recovery time = 16.3ms, 307 × 384 matrix, x reso-
lution = 0.365mm, y resolution = 0.456mm, and total slice
number = 160. These sequences have been described in
detail elsewhere [10].
Semi-quantitative structural features
For all semi-quantitative and quantitative outcomes, the
readers were blinded to group assignment and were un-
blinded to the order of time. Two musculoskeletal
radiologists (RW:255 cases, JM:120 cases) performed the
semi-quantitative MR readings. Readers had good agree-
ment on the presence of each pathology among 25 cases:
prevalence-adjusted and bias-adjusted kappa were 0.41
to 0.75 except for the posterior horn of the medial me-
niscus where the prevalence-adjusted and bias-adjusted
kappa was fair at 0.25 (50% agreement).
The radiologists assessed the integrity of anterior/pos-
terior cruciate ligaments, medial/lateral collateral liga-
ments, extensor mechanism, and gastrocnemius proximal
tendons and noted if the structures appeared normal or
degenerative. Degenerative tissue was defined as the pres-
ence of abnormal intrinsic high-signal intensity within the
substance of the ligaments or tendon without discrete
tear. Degenerative cruciate ligament pathology combined
the presence of anterior or posterior cruciate ligament de-
generative pathology. Degenerative collateral ligament
pathology combined the presence of medial or lateral col-
lateral ligament degenerative pathology.
The radiologists scored infrapatellar fat pad signal inten-
sity alteration using the MR Imaging Osteoarthritis Knee
Score grading system (i.e., normal, mild, moderate, and se-
vere) [12]. Infrapatellar fat pad signal intensity was
recoded as absence (i.e., normal) or presence (i.e., mild,
moderate, and severe).
The radiologists scored medial and lateral meniscus
extrusion using the MR Imaging Osteoarthritis Knee
Score grading system (i.e., Grade 0: < 2 mm, Grade 1: 2
to 2.9 mm, Grade 2: 3 to 5 mm, and Grade 3: > 5mm)
[12]. Meniscal extrusion was recoded as absence (i.e.,
Grade 0) or presence (i.e., > Grade 1).
The radiologists used the International Society of Arthros-
copy, Knee Surgery, and Orthopaedic Sports Medicine
meniscal tear classification, which was modified for MR im-
aging [13], to assess the body, posterior/anterior horn of
each meniscus as: normal, degeneration, horizontal, flap
horizontal, vertical longitudinal, radial, morphologic deform-
ity, maceration, complex, or vertical flap tear. Meniscal path-
ology was recoded as absence (i.e., normal or degeneration
without tear) and presence (i.e., horizontal, flap horizontal,
vertical longitudinal, radial, morphologic deformity, macer-
ation, complex, or vertical flap tear). For the medial/lateral
menisci, pathology in the three regions meniscal tears of dif-
ferent morphologies were combined into the same variable.
The medial/lateral menisci were considered pathologic if
pathology was present in any of the three regions.
Quantitative structural features
Effusion-synovitis volume We used a customized
semi-automatic software to measure knee effusion-syno-
vitis. Two readers (JBD and a visiting fellow) used the
software to mark the first and last MR slice that in-
cluded bone, the proximal border of the patella, and the
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apex of the fibular head on a central slice. The software
then automatically segmented effusion-synovitis between
these limits based on an existing threshold. The senior
reader (JBD) then manually adjusted the threshold to
change the effusion-synovitis boundaries and removed
areas of high signal intensity that were not
effusion-synovitis (e.g., subchondral cysts, blood vessels).
The senior reader demonstrated excellent intra-reader
reliability (ICC3,1 = 0.96). A total knee effusion-synovitis
volume (in cm3) was used for data analysis.
Bone marrow lesion volume One reader (ACS) mea-
sured tibiofemoral BML volume with a semi-automated
segmentation method [14, 15]. The only manual step re-
quired the reader to identify crude boundaries of the
tibia and femur in each slice of the MR images. The
boundary furthest from the articular surfaces was
marked just prior to the epiphyseal line or at the edge of
the bone and soft tissue. The program then automatic-
ally identified the precise bone boundaries and per-
formed a thresholding and curve evolution process twice
to segment areas of high signal intensity, which may rep-
resent a BML. We eliminated false-positive regions by
operationally defining a BML based on 2 criteria: 1) the
distance between a BML to the articular surface should
be < 10mm; 2) a BML needed to span more than one
MR image. The study principal investigator (JBD)
reviewed all measurements with both timepoints on
screen simultaneously. Our reader demonstrated excel-
lent intra-reader reliability (ICC3,1 = 0.91). A total tibio-
femoral BML volume (in cm3) was used for data
analysis.
Cartilage damage index The validated cartilage damage
index (CDI) was used to quantify tibiofemoral cartilage
size [16, 17]. One reader (JED) manually marked the
bone-cartilage boundary on specific knee slices that are
automatically selected based on the width of the knee.
The reader then measured cartilage thickness at pre-
defined informative locations, which the software
automatically located. The software then computed
the CDI for the medial femur, lateral femur, medial
tibia, and lateral tibia by summing the products of
cartilage thickness, cartilage length (anterior-poster-
ior), and voxel size from 9 informative locations in
each compartment. All measurements were reviewed
by study principal investigator. Our reader demon-
strated excellent intra-reader reliability (ICC3,1 = 0.86
to 0.99). The sum of all four tibiofemoral compart-
ment CDI values was divided by the participant’s
height to calculate a normalized total tibiofemoral
CDI that was used for data analysis.
Clinical data
Demographic and other participant characteristics were
acquired based on a standard protocol. We extracted
age, body mass index, global impact rating, frequent
knee pain and Western Ontario and McMaster Univer-
sities Osteoarthritis Index (WOMAC) pain at the OAI
baseline visit. The data are publicly available (Files: allcli-
nical0#; version 0.2.2, 1.2.1, 3.2.1, 5.2.1, and 6.2.1) [11].
Data analysis
For the continuous quantitative outcomes, the variables
in the entire cohort were separated into tertiles and con-
verted to a dichotomous variable to compare the worst
tertile (i.e. largest BML and effusion-synovitis, smallest
CDI) to the combination of the other two tertiles to fa-
cilitate the interpretation of the odds ratios.
Statistical analysis
Primary analysis
Are Early Pre-Radiographic Structural Features Associ-
ated with the Onset of Accelerated Knee Osteoarthritis?
Separate logistic regression models were used to deter-
mine which pre-radiographic structural features at OAI
baseline were more likely to antedate the development
of AKOA compared to individuals not developing
AKOA (i.e. referent group). Additionally, we conducted
the same analyses for each structural outcome at 2 and
1 years prior to the index visit. The results are presented
as odds ratios (ORs) and 95% confidence intervals (95%
CIs). To control for multiple comparisons, we utilized a
statistically significant p-value corrected for the number
of structural features utilized in the primary OAI base-
line analysis (p < 0.05/12 = 0.004).
Secondary analysis
Which Combination of Baseline Pre-Radiographic Struc-
tural Features Most Associate with the Onset of Acceler-
ated Knee Osteoarthritis?
To explore which combination of pre-radiographic
structural features characterize AKOA, we performed a
backward stepwise logistic regression where the outcome
was AKOA or no AKOA (referent group) at the OAI
baseline. Separate models also were conducted for 2 and
1 years prior to the index visit. All 9 semi-quantitative
and 3 quantitative pre-radiographic structural features
were included in the analysis at each time point. The
ability for the combination of pre-radiographic structural
features to discriminate between AKOA status was
quantified with the C statistic [18]. The discriminatory
ability of a model based on the C statistic was classified
as: very poor (C < 0.50), poor (0.50 < C < 0.70), good
(0.70 < C < 0.80), and strong (0.80 < C < 1.00) [19].
All analyses were performed unadjusted, as the pur-
pose of this investigation was to specifically determine
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the prognostic capability of baseline structural features
at associating with future development of incident
AKOA. Due to missing MR images at different OAI
visits, there are different sample sizes depending on the
analysis: OAI baseline (n = 354), 2 years prior to onset
(n = 248), 1 years prior to onset (n = 354). There are un-
even sample sizes at the different time points because
some participants are unable to have a 2 year prior to
onset visit (i.e., index visit at the 1-year OAI visit). We
conducted a sensitivity analysis for the OAI baseline and
1 year prior to onset analyses limiting the sample to the
248 participants in the 2 years prior to onset analysis. All
analyses were performed with SAS Enterprise 7.15 (Cary,
NC, USA).
Results
Table 1 details the demographics for each group.
Primary analysis
Are Pre-Radiographic Structural Features Associated
with the Onset of Accelerated Knee Osteoarthritis?
At the OAI baseline visit, degenerative cruciate liga-
ments (OR = 2.15; 95%CI = 1.34, 3.45; p = 0.002 Table 2),
infrapatellar fat pad signal intensity alteration (OR =
1.98; 95%CI = 1.24, 3.15; p = 0.004), medial meniscal
pathology (OR = 2.14; 95%CI = 1.33, 3.43; p = 0.002), lat-
eral meniscal pathology (OR = 2.36; 95%CI = 1.47, 3.79;
p = 0.0004), and large effusion-synovitis volume (effusion
cutoff > 9.5cm3; OR = 2.15; 95%CI = 1.35, 3.43; p = 0.001)
were more likely to antedate the development of AKOA
when compared to those that did not develop AKOA.
At 2 years prior to disease onset, the same structural
features from the OAI baseline analysis were more com-
mon in individuals prior to the development of AKOA
when compared to those that did not develop AKOA
(Table 3). The effusion cutoff at 2 years prior to disease
onset was 9.8cm3.
At 1 year prior to disease onset, all significant features
from the OAI baseline analysis were more common in
individuals prior to the development of AKOA when
compared to those that did not develop AKOA (Table 4).
Additionally, we found that the presence of medial me-
niscus extrusion (OR = 3.52; 95%CI = 2.07, 6.00) in-
creased the likelihood of developing AKOA when
compared to individuals who did not develop AKOA.
The effusion cutoff at 2 years prior to disease onset was
11.9cm3.
Secondary analysis
Which Combination of Baseline Pre-Radiographic Struc-
tural Features Most Associate with the Onset of Acceler-
ated Knee Osteoarthritis?
At the OAI baseline, the combination of medial
meniscal pathology, degenerative cruciate ligaments,
greater effusion-synovitis volume, and lateral meniscal
pathology provided good discrimination between indi-
viduals that would develop AKOA within the next four
years and individuals that would not develop AKOA
(C-statistic = 0.70).
At 2 years prior to disease onset, the pre-radiographic
structural features included in the OAI baseline analysis
plus degenerative collateral ligaments provided good dis-
crimination between individuals that would develop
AKOA within the next four years and individuals that
would not develop AKOA (C-statistic = 0.76).
At 1 year prior to disease onset, the combination of
medial meniscal pathology, degenerative cruciate liga-
ments, greater effusion-synovitis volume, infrapatellar fat
pad signal intensity alteration, and medial meniscal ex-
trusion provided good discrimination between individ-
uals that would develop AKOA within the next four
years and individuals that would not develop AKOA
(C-statistic = 0.77).
The sensitivity analyses in the OAI baseline and the
one year prior to disease cohorts that limited the sample
size to the 248 individuals (i.e., participants included in
the 2 years prior to disease cohort) did not alter the find-
ings of any of the analyses.
Discussion
In this longitudinal study we found that several struc-
tural pathologies preceding the onset of radiographic
knee OA increased the risk for the subsequent develop-
ment of AKOA compared to individuals who did not de-
velop AKOA. At the OAI baseline visit, the presence of
degenerative ligaments, effusion-synovitis, and meniscal
pathology were identified as pre-radiographic structural
features that identified an increased risk of AKOA devel-
opment over the next four years. Medial meniscal extru-
sion was additionally associated with AKOA at 1 year
before the onset of disease. Thus, these pre-radiographic
Table 1 Baseline Descriptive Characteristics of Individuals with
and without Incident Accelerated Knee Osteoarthritis (AKOA)
Variables AKOA No AKOA
[(means (SD); except where noted) (n = 113) (n = 241)
Females, n(%) 71(63%) 151(63%)
Index knee KL Grade = 0, n(%)a 37(33%) 157(65%)
Frequent knee pain in past 12 months, n(%) 62(57%) 75(31%)
Age (years) 65.6(8.4) 60.1(8.4)
Body mass index (kg/m2) 29.5(4.4) 27.5(4.5)
Global impact rating (0 to 10; ↑score = ↑ impact) 2.2(2.1) 1.0(1.4)
WOMAC pain (0 to 20; ↑score = ↑pain) 3.4(3.7) 1.6(2.6)
aIndex knee Kellgren-Lawrence (KL) grade could be 0 or 1. SD standard
deviation, WOMAC Western Ontario and McMaster Universities Osteoarthritis
Index, kg/m2 kilogram per meters squared
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structural features, especially these more proximate find-
ings, antedate the development of AKOA and may help
identify individuals likely to develop AKOA in the near
future.
These results were consistent, and not attenuated,
even when mutually adjusted for in multivariate models,
as we observed that the combination of medial meniscal
pathology, degenerative cruciate ligaments, and the
greatest tertile of quantitative knee effusion-synovitis
volume (> 9.5cm3) at OAI baseline were associated with
the future development of AKOA. Furthermore, the
pre-radiographic structural features that associated with
AKOA depended on the proximity of time between the
image assessment and the onset of disease. Specifically,
at 2 years prior to disease development, lateral meniscal
pathology and degenerative collateral ligaments were
also associated with AKOA and included in the multi-
variate model. At the year prior to disease development,
infrapatellar fat pad signal intensity alteration and med-
ial meniscal extrusion were associated with AKOA and
included in the multivariate model. Therefore, depend-
ing on the time to disease onset, different combinations
of pre-radiographic structural features may be most indi-
cative of future AKOA development and may help us
eventually determine their risk of AKOA over 1, 2 or 4
years.
We consistently observed that regardless of time, the
presence of meniscal pathology was associated with fu-
ture AKOA development. These findings complement
previous research where we observed that incident
AKOA was often characterized by medial meniscal tears
with moderate-severe extrusion or changes in meniscal
size [5], as well as other studies that have observed that
meniscal pathology [20] and meniscal extrusion [21]
were related to knee OA onset. Additionally, individuals
with medial meniscal extrusion at the year prior to dis-
ease development are approximately 3.5 times more
likely to develop AKOA. Meniscal extrusion was not as-
sociated with AKOA at any other timepoints. This indi-
cates that medial meniscal extrusion may be a later
Table 2 Baseline Pre-Radiographic Structural Features Associated with Accelerated Knee Osteoarthritis (OA) Over the Next 4 Years
Structural Feature Group
AKOA (n = 113) No AKOA (Reference, n = 241) Univariate Odds Ratio
n (%) n (%) OR (95% CI)
Semi-Quantitative Degenerative Cruciate Ligaments Absence 66 (58%) 181 (75%) Reference
Presence 47 (42%) 60 (25%) 2.15 (1.34, 3.45)*
Degenerative Collateral Ligaments Absence 88 (78%) 206 (85%) Reference
Presence 25 (22%) 35 (15%) 1.67 (0.95, 2.96)
Degenerative Extensor Mechanism Absence 64 (57%) 163 (68%) Reference
Presence 49 (43%) 78 (32%) 1.60 (1.01, 2.53)
Degenerative Gastrocnemius Tendon Absence 64 (57%) 146 (61%) Reference
Presence 49 (43%) 95 (39%) 1.18 (0.75, 1.85)
Infrapatellar Fat Pad Signal Intensity Alteration Absence 63 (56%) 172 (71%) Reference
Presence 50 (44%) 69 (29%) 1.98 (1.24, 3.15)*
Medial Meniscal Pathology Absence 35 (31%) 118 (49%) Reference
Presence 78 (69%) 123 (51%) 2.14 (1.33, 3.43)*
Lateral Meniscal Pathology Absence 64 (57%) 182 (76%) Reference
Presence 49 (43%) 59 (24%) 2.36 (1.47, 3.79)*
Medial Meniscal Extrusion Absence 90 (80%) 210 (87%) Reference
Presence 23 (20%) 31 (13%) 1.73 (0.96, 3.13)
Lateral Meniscal Extrusion Absence 109 (96%) 238 (99%) Reference
Presence 4 (4%) 3 (1%) 2.91 (0.64, 13.23)
Quantitative Effusion-Synovitis Volume^ Smallest 63 (56%) 176 (73%) Reference
Largest 50 (44%) 65 (27%) 2.15 (1.35, 3.43)*
Bone Marrow Lesion Volume^ Smallest 78 (69%) 161 (67%) Reference
Largest 35 (31%) 80 (33%) 0.90 (0.56, 1.46)
Cartilage Damage Index^ Largest 79 (70%) 159 (66%) Reference
Smallest 34 (30%) 82 (34%) 0.84 (0.52, 1.35)
*Statistically significant: p < 0.004. ^Comparing the worst tertile (i.e. largest effusion-synovitis /bone marrow lesion, smallest CDI) to the other 2 tertiles
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finding that becomes relevant in the year prior to the
onset of advanced-stage disease (KL = 3 or 4). While our
analyses limit us from making causal inferences, previ-
ous biomechanical studies [22, 23] have observed that
medial meniscal pathology results in increased tibiofe-
moral contact pressure and alterations in knee kinemat-
ics which may lead to overloading of the knee joint.
Additionally, meniscal pathology and meniscal extrusion
are key risk factors for fast cartilage loss [24–26]. There-
fore, disruption of the medial meniscus may be related
to the rapid decline in joint health which is why there is
an association with future AKOA development.
Our results indicate that regardless of time, individuals
with cruciate ligament degeneration are more than twice
as likely to develop AKOA. Despite the apparent import-
ance of cruciate ligament degeneration, the main
semi-quantitative whole joint scoring systems only assess
for acute tear and do not provide an indicator of cruciate
ligament degeneration [27, 28], even though previous
findings have observed an association between
degenerative cruciate ligaments and symptomatic KOA
[29]. The main function of the cruciate ligaments are to
facilitate rotational and translational stability to the knee
joint [30], and degenerative cruciate ligaments present
with altered fiber arrangement and collagen composition
[31, 32]. Additionally, individuals with cruciate ligament
degeneration present with greater severity of cartilage
damage, bone marrow lesions, subchondral cysts, and
lateral meniscus pathology when compared to individ-
uals with normal cruciate ligaments [33]. While we are
unable to make definitive claims based on our results,
cruciate ligament degeneration could be early evidence
of a maladaptation to loading or due to aberrant joint
loading created by impaired ligamentous function that
increases knee instability or laxity [34]. Future studies
are needed to confirm whether the presence of knee in-
stability increases the risk for incident AKOA. If instabil-
ity is present, then it may explain the increased meniscal
damage and large effusion-synovitis commonly observed
among knees that develop AKOA [5].
Table 3 Pre-Radiographic Structural Features at 2 Years Prior to Disease Onset Associated with Accelerated Knee Osteoarthritis
Structural Feature Group
AKOA (n = 90) No AKOA (Reference, n = 158) Univariate Odds Ratio
n (%) n (%) OR (95% CI)
Semi-Quantitative Degenerative Cruciate Ligaments Absence 52 (58%) 120 (76%) Reference
Presence 38 (42%) 38 (24%) 2.31 (1.33, 4.02)*
Degenerative Collateral Ligaments Absence 69 (77%) 140 (89%) Reference
Presence 21 (23%) 18 (11%) 2.37 (1.18, 4.73)*
Degenerative Extensor Mechanism Absence 50 (56%) 111 (70%) Reference
Presence 40 (44%) 47 (30%) 1.89 (1.10, 3.24)*
Degenerative Gastrocnemius Tendon Absence 46 (51%) 95 (60%) Reference
Presence 44 (49%) 63 (40%) 1.44 (0.86, 2.43)
Infrapatellar Fat Pad Signal Intensity Alteration Absence 45 (50%) 112 (71%) Reference
Presence 45 (50%) 46 (29%) 2.44 (1.42, 4.17)*
Medial Meniscal Pathology Absence 26 (29%) 85 (54%) Reference
Presence 64 (71%) 73 (46%) 2.87 (1.65, 4.98)*
Lateral Meniscal Pathology Absence 49 (54%) 121 (77%) Reference
Presence 41 (46%) 37 (23%) 2.74 (1.57, 4.76)*
Medial Meniscal Extrusion Absence 73 (81%) 142 (90%) Reference
Presence 17 (19%) 16 (10%) 2.07 (0.99, 4.33)
Lateral Meniscal Extrusion Absence 87 (97%) 157 (99%) Reference
Presence 3 (3%) 1 (1%) 5.41 (0.56, 52.84)
Quantitative Effusion-Synovitis Volume^ Smallest 46 (51%) 120 (76%) Reference
Largest 44 (49%) 38 (24%) 3.02 (1.74, 5.24)*
Bone Marrow Lesion Volume^ Smallest 62 (69%) 105 (66%) Reference
Largest 28 (31%) 53 (34%) 0.90 (0.51, 1.56)
Cartilage Damage Index^ Largest 62 (69%) 103 (65%) Reference
Smallest 28 (31%) 55 (35%) 0.85 (0.49, 1.47)
*Statistically significant: p < 0.004. ^Comparing the worst tertile (i.e. largest effusion-synovitis /bone marrow lesion, smallest CDI) to the other 2 tertiles
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Knee effusion-synovitis volume may be the
pre-radiographic structural feature most strongly associ-
ated with future AKOA development. At 2 years prior to
disease development, individuals with effusion-synovitis
greater than 11.9 cm3 are about 3 times more likely to
develop AKOA, with this likelihood increasing to ~ 5.2
times in the year prior to the onset of advanced-stage
disease. Effusion-synovitis has previously been observed
to precede radiographic knee OA, and is theorized to be
a consequence of early, underlying damage occurring
within the knee [20, 35]. Therefore, all of the pathologic
and degenerative tissues in the joint may contribute to
greater knee effusion-synovitis. Furthermore, the
effusion-synovitis may be a secondary sign of maladapta-
tion to loading that is stressing other tissues in the joint.
This study offers new knowledge indicating that individ-
uals in the greatest tertile effusion-synovitis prior to OA
onset are more likely to develop AKOA when compared
to individuals with less effusion-synovitis. Individuals
with AKOA have greater pain than those with typical
knee OA [2] and this may be partially attributable to
their large effusion-synovitis, which is associated with in-
creased pain [36, 37]. Therefore, the association between
AKOA and increased pain may be mediated by greater
knee effusion-synovitis. However, future investigations
are needed to determine the specific mechanisms lead-
ing to increased pain and effusion-synovitis in individ-
uals with knee OA.
This study provides a critical initial step in determin-
ing which pre-radiographic structural features may serve
as future prognostic imaging markers of AKOA; how-
ever, there are some limitations that must be discussed.
Our analyses are not able to provide evidence of specific
causal pathways between the identified pre-radiographic
structural features and AKOA development, but only
that the presence of these features precedes the eventual
AKOA development. Future studies are needed to con-
firm that these structural features are prognostic and
mechanistically involved in the development of AKOA.
This study indicates which individual pre-radiographic
Table 4 Pre-Radiographic Structural Features at 1 Years Prior to Disease Onset Associated with Accelerated Knee Osteoarthritis
Structural Feature Group
AKOA (n = 112) No AKOA (Reference, n = 242) Univariate Odds Ratio
n (%) n (%) OR (95% CI)
Semi-Quantitative Degenerative Cruciate Ligaments Absence 64 (57%) 180 (74%) Reference
Presence 48 (43%) 62 (26%) 2.18 (1.36, 3.49)*
Degenerative Collateral Ligaments Absence 86 (77%) 206 (85%) Reference
Presence 26 (23%) 36 (15%) 1.73 (0.99, 3.04)
Degenerative Extensor Mechanism Absence 62 (55%) 165 (68%) Reference
Presence 50 (45%) 77 (32%) 1.73 (1.09, 2.74)*
Degenerative Gastrocnemius Tendon Absence 63 (56%) 140 (58%) Reference
Presence 49 (44%) 102 (42%) 1.07 (0.68, 1.68)
Infrapatellar Fat Pad Signal Intensity Alteration Absence 53 (47%) 169 (70%) Reference
Presence 59 (53%) 73 (30%) 2.58 (1.63, 4.09)*
Medial Meniscal Pathology Absence 23 (21%) 115 (48%) Reference
Presence 89 (79%) 127 (52%) 3.50 (2.08, 5.91)*
Lateral Meniscal Pathology Absence 63 (56%) 180 (74%) Reference
Presence 49 (44%) 62 (26%) 2.26 (1.41, 3.62)*
Medial Meniscal Extrusion Absence 72 (64%) 209 (86%) Reference
Presence 40 (36%) 33 (14%) 3.52 (2.07, 6.00)*
Lateral Meniscal Extrusion Absence 103 (92%) 237 (98%) Reference
Presence 9 (8%) 5 (2%) 4.14 (1.36, 12.66)
Quantitative Effusion-Synovitis Volume^ Smallest 46 (41%) 190 (79%) Reference
Largest 66 (59%) 52 (21%) 5.24 (3.23, 8.52)*
Bone Marrow Lesion Volume^ Smallest 69 (62%) 169 (70%) Reference
Largest 43 (38%) 73 (30%) 1.44 (0.90, 2.31)
Cartilage Damage Index^ Largest 73 (65%) 164 (68%) Reference
Smallest 39 (35%) 78 (32%) 1.12 (0.70, 1.80)
*Statistically significant: p < 0.004. ^Comparing the worst tertile (i.e. largest effusion-synovitis/bone marrow lesion, smallest CDI) to the other 2 tertiles
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structural features may increase the risk of AKOA devel-
opment, however, we are unable to confirm how each
pathologic finding is dependent on another. Therefore,
future studies are needed to determine if each structural
feature is a different pathway to the same outcome (i.e.
AKOA), if the features are various manifestations due to
the same underlying process, or if there are particular
combinations of features leading to AKOA. We assessed
knee effusion-synovitis using non-contrast enhanced MR
images even though contrast-enhanced MR images are
considered the gold standard. Due to the possible com-
plications, increased price, lack of clinical feasibility in a
pre-radiographic population the non-contrast MR was
selected for the OAI protocol [10]. However, even when
using the non-contrast MR imaging, we observed signifi-
cant associations between knee effusion-synovitis and
AKOA development. Meniscal tears of different morph-
ologies were collapsed into the same variable of meniscal
pathology due to small sample sizes of the individual
types of tears. Since different meniscal tears have differ-
ent biomechanical significance to the knee [38], future
studies should attempt to individually determine the sig-
nificance of specific meniscal tears. Two musculoskeletal
radiologists performed the semi-quantitative structural
readings with an uneven distribution of cases (RW =
225, JM = 120); however, our readers demonstrated good
agreement that is similar to previous semi-quantitative
readings [39].
Conclusions
In conclusion, this study indicates specific early struc-
tural features (e.g. degenerative ligaments, effusion/syno-
vitis, and meniscal) that may be evidence of early
maladaptation to loading that precedes the onset of
AKOA. These findings should be considered as potential
prognostic biomarkers that warrant further study.
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